TG Therapeutics
TGTX
TGTX
346 hedge funds and large institutions have $3.07B invested in TG Therapeutics in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 129 increasing their positions, 110 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $3.58B → $3.07B (-$508M)
17% less call options, than puts
Call options by funds: $62M | Put options by funds: $74.9M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
346
Holding in Top 10
4
Calls
$62M
Puts
$74.9M
Top Buyers
| 1 | +$62.8M | |
| 2 | +$20M | |
| 3 | +$17.9M | |
| 4 |
Goldman Sachs
New York
|
+$17.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$16.8M |
Top Sellers
| 1 | -$39.1M | |
| 2 | -$23M | |
| 3 | -$21.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.8M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$13.5M |
